Status:
NOT_YET_RECRUITING
Investigation Of The Effects Of Anti-Tnf-Α And Non-Tnf-Α Drugs İn Patients With Rheumatoid Arthritis
Lead Sponsor:
Firat University
Conditions:
Rheumatoid Arthritis (RA
Eligibility:
FEMALE
18-65 years
Brief Summary
In RA, joint structure is damaged due to destructive inflammation in the synovium. This condition negatively affects the patient's level of physical activity. As the patient becomes more immobile, the...
Detailed Description
The basic principle in the treatment of rheumatoid arthritis is to prolong the period of remission in patients. Even if complete remission is not achieved, improvements in symptoms and clinical findin...
Eligibility Criteria
Inclusion
- Diagnosed with RA according to the 2010 American College of Rheumatology (ACR-2010) criteria
- Be between 18 and 65 years of age
- Be literate
- Have been using one of the anti-TNF-α or non-TNF-α drugs for a period of 1-3 years
Exclusion
- Being pregnant or having a diagnosis of malignancy
- Having a dysfunction that would limit physical activity (cycling for aerobic capacity assessment), such as severe neurological involvement, immobility, or incooperation
- Having a regular exercise habit (reporting a habit of exercising 3 or more days per week)
- Having another chronic disease
- Having cardiac symptoms according to the New York Heart Association
- Having mental problems that prevent participation in assessments
Key Trial Info
Start Date :
October 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 30 2026
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT07182630
Start Date
October 1 2025
End Date
January 30 2026
Last Update
September 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fırat University
Elâzığ, Turkey (Türkiye)